Hydroxycarteolol
Jump to navigation
Jump to search
Clinical data | |
---|---|
Other names | 8-Hydroxycarteolol |
ATC code |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
ChEBI | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C16H24N2O4 |
Molar mass | 308.378 g·mol−1 |
3D model (JSmol) | |
| |
|
Hydroxycarteolol is a beta blocker and metabolite of carteolol.[1][2]
References
- ^ Igarashi H, Katsuta Y, Sawa K, Nakazato Y, Kawasaki T (Apr 1990). "A comparison of the opacifying effects of carteolol.HCl and 8-hydroxycarteolol.HCl in the isolated porcine cornea". Fundam Appl Toxicol. 14 (3): 554–559. doi:10.1093/toxsci/14.3.554. PMID 2340982.
- ^ Jasper JR, Michel MC, Insel PA (1990). "The beta-adrenoceptor antagonist carteolol and its metabolite 8-hydroxycarteolol have different intrinsic sympathomimetic activities". Br J Clin Pharmacol. 30 (Suppl 1): 109S–111S. doi:10.1111/j.1365-2125.1990.tb05477.x. PMC 1368107. PMID 2176514.
Categories:
- Articles with short description
- Short description matches Wikidata
- Drugs not assigned an ATC code
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without UNII source
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Beta blockers
- 4-Quinolones
- Human drug metabolites
- Quinolinols
- Secondary alcohols
- Tert-butyl compounds
- All stub articles
- Cardiovascular system drug stubs